<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250720066558N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-08-15</date_registration>
      <primary_sponsor>Ahvaz University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the Effect of Sensorimotor Exercises on Repetitive Behaviors in Children with Autism</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effect of sensory integration approach on stereotyped behaviors of children with autism spectrum disorder</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-11-16</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/85207</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: To allocate 60 participants into two groups of 30 each, a randomization method using blocks of 4 was employed. In this method, each block consisted of 4 individuals, evenly divided between the two groups (two participants in the intervention group and two in the control group). First, all possible combinations of this type of allocation (such as AABB, ABAB, ABBA, etc.) were entered into Excel software. Then, 15 blocks were randomly selected from these combinations so that a total of 60 participants were evenly and randomly assigned to the two groups. To generate random combinations, the Rand Between and Index functions in Excel were used, determining each individual's placement in the intervention or control group. Finally, the results were manually saved to ensure no changes occurred in the allocation after determination.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Autism Spectrum Disorder.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intervention is conducted over 11 consecutive weeks, with 11 sessions using tools such as a soft brush, massager, and ball pool, each session lasting 45 minutes. Sessions are held twice a week by the occupational therapist of the education center under the supervision of the principal investigator. After 11 sessions, the severity of stereotyped behaviors in both groups is reassessed using the GARS tool. The effectiveness of this intervention is evaluated by analyzing the final questionnaire results. Intervention 2: Control group: The control group participants will not receive any sensory integration intervention during the study period and will only receive the usual educational and rehabilitation services and programs of the center. After the completion of the study, if they wish, the sensory integration intervention will also be provided to this group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
De-identified individual participant data, including results for the primary outcome measure (GARS questionnaire scores), will be available upon reasonable request from qualified researchers after completion of data analysis. Other raw data will be shared only in aggregate form without any possibility of identifying participants.

When:
Access to de-identified individual participant data will be available starting 6 months after publication of the study results and will remain open for 3 years. Access will be granted only to qualified researchers upon submission of a reasonable request and approval by the principal investigator

To whom:
Data and study documents will be available only to qualified researchers affiliated with accredited academic institutions or recognized research centers, upon submission of a written request and approval by the principal investigator

Conditions:
Access to anonymized data and study documents will be granted only to researchers affiliated with academic and scientific institutions. Requestors must submit a formal application describing the intended analyses. Use of the data and documents is limited to approved research purposes, and any further sharing or publication requires prior permission from the study’s principal investigator. Compliance with ethical guidelines and confidentiality agreements is mandatory

Where to obtain:
Applicants requesting study documents or data can submit their written requests via email to the principal investigator. If postal correspondence is required, they may contact the following postal address at Jundishapur University of Medical Sciences, Ahvaz. Contact details are as follows:

Contact Person: Dr. Hossein Kemili Sani
Email: hossein.kemili@ajums.ac.ir
Postal Address: Golestan Street, Jundishapur University of Medical Sciences, Ahvaz, Postal Code 61357-14551, Iran
Phone Number: +98 61 3333 1234
Fax Number: +98 61 3333 5678
Priority for receiving requests is via email, and if official documents or formal correspondence are needed, they will be handled through the postal address.

How to obtain:
Applicants must submit a written request via email or postal mail to the study coordinator. Upon receipt, the request will undergo an initial review by the research team to ensure completeness and validity. Then, the request will be forwarded to the ethics committee and relevant authorities for approval. This process typically takes 2 to 4 weeks. Once approved, de-identified documents or data files will be sent to the applicant electronically. If printed copies or official documents are required, additional time will be needed depending on the delivery method

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Marzie Zakernejad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 17, Nazem Street, Shariati Neighborhood, by the river</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6197870008</zip>
        <telephone>+98 61 3550 7191</telephone>
        <email>marzie.zakernejad@gmail.com</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Marzie Zakernejad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 17, Nazem Street, Shariati Neighborhood, by the river</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6197870008</zip>
        <telephone>+98 61 3550 7191</telephone>
        <email>marzie.zakernejad@gmail.com</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Diagnosis of autism spectrum disorder with mild to moderate severity
Enrollment in exceptional education centers for children with autism spectrum disorder in Ahvaz
Willingness and consent of the parents of these individuals to participate in the study
Regular use of Risperidone and Ritalin medications according to parents’ report</inclusion_criteria>
      <agemin>4 years</agemin>
      <agemax>10 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Concurrent diagnosis of severe psychiatric disorders such as psychosis, severe bipolar disorder, personality disorder, or uncontrolled epilepsy
Diagnosis of blindness or deafness</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F84.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Autistic disorder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intervention is conducted over 11 consecutive weeks, with 11 sessions using tools such as a soft brush, massager, and ball pool, each session lasting 45 minutes. Sessions are held twice a week by the occupational therapist of the education center under the supervision of the principal investigator. After 11 sessions, the severity of stereotyped behaviors in both groups is reassessed using the GARS tool. The effectiveness of this intervention is evaluated by analyzing the final questionnaire results.</i_keyword>
      <i_keyword>Control group: The control group participants will not receive any sensory integration intervention during the study period and will only receive the usual educational and rehabilitation services and programs of the center. After the completion of the study, if they wish, the sensory integration intervention will also be provided to this group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Change in the severity of stereotyped behaviors in children with autism spectrum disorder based on the GARS questionnaire score. Timepoint: Before and after the intervention (after 11 sessions of the sensory integration approach). Method of measurement: Gilliam Autism Rating Scale (GARS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Ahvaz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-07-15</approval_date>
        <contact_name>Ethics Committee of Jundishapur University of Medical Sciences</contact_name>
        <contact_address>No. 17, Nazem Street, Shariati Street End, Jomhouri Alley اهواز Khouzestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
